Marked increase in MTA1 levels, which is an indicator of advanced castrate‐resistant prostate tumors, might be an important factor in endorsing CTSB‐mediated degradation of basement membrane and in the ability of primary prostate tumor cells to undergo E‐cad‐mediated EMT. Here, MTA1 is linked to prostate neoplasm.